Dexcom stock price traded at $125

Dexcom stock price traded at $125.30 today, with volume 20% above the 30-day average, reflecting heightened market interest. Analysts project EPS growth of 18% for FY2024, reinforcing the bullish case. Marvell Technology (MRVL) is down more than -1% to lead losers in the Nasdaq 100 after TD Cowen downgraded the stock to hold from buy. Adjusted gross profit totaled $695.9 million, up 9.1% from the prior-year quarter’s level. DexCom reported an adjusted gross margin (as a percentage of revenues) of 60.1%, down 340 basis points year over year. Shares of Dexcom, marked by a $123.20 stock price close, continue to benefit from strong sector-wide healthtech ETF inflows, signaling improved investor appetite for growth-oriented medical device firms.